Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Mallinckrodt
Dow
Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Gadoxetate disodium - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for gadoxetate disodium and what is the scope of freedom to operate?

Gadoxetate disodium is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Gadoxetate disodium has thirty-three patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for gadoxetate disodium
International Patents:33
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 6
Clinical Trials: 5
Formulation / Manufacturing:see details
DailyMed Link:gadoxetate disodium at DailyMed
Recent Clinical Trials for gadoxetate disodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nova Scotia Health AuthorityPhase 4
Slawa CwajnaPhase 4
Duke UniversityPhase 4

See all gadoxetate disodium clinical trials

Pharmacology for gadoxetate disodium
Synonyms for gadoxetate disodium
135326-22-6
222726-20-7
Bay 86-4873
BCP09445
D04288
Disodium (N-((2S)-2-(bis(carboxymethyl)amino)-3-(p-ethoxyphenyl)propyl)-N-(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))gadolinate(2-)
Eovist
Eovist (TN)
Eovist injection
Gadolinate(2-), (N-(2-(bis((carboxy-kappaO)methyl)amino-kappaN)-3-(4-ethoxyphenyl)propyl)-N-(2-(bis((carboxy-kappaO)methyl)amino-kappaN)ethyl)glycinato(5-)-kappaN,kappaO)-, disodium, (SA-8-11252634-(S))-
Gadolinium EOB DTPA
Gadolinium Ethoxybenzyl Dtpa
Gadoxetate disodium (USAN)
Gadoxetate Disodium [USAN]
Gadoxetate sodium (JAN)
Gadoxetic acid disodium
Gd-(S)-EOB-DTPA
HOY74VZE0M
HSDB 8233
UNII-HOY74VZE0M
ZK 139834

US Patents and Regulatory Information for gadoxetate disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-001 Jul 3, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-002 Feb 4, 2013 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for gadoxetate disodium

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0405704 300182 Netherlands   Start Trial 300182, 20100627, EXPIRES: 20150626
0405704 16/2005 Austria   Start Trial PRODUCT NAME: GADOXETSAEURE DINATRIUM; NAT. REGISTRATION NO/DATE: 1-25757, 1-25758 20050302; FIRST REGISTRATION: SE 18929, 18930 20040326
0405704 C300182 Netherlands   Start Trial PRODUCT: GADOXETINEZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT, IN HET BIJZONDER HET NATRIUMZOUT. FIRST AUTHORIZATION NO/DATE: 1829 AND 18930, 20040326 (SE); NATIONAL AUTHORIZATION NO/DATE: RVG 31393 AND 31394, 20050113
0405704 C00405704/01 Switzerland   Start Trial FORMER OWNER: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE
0405704 SPC/GB05/021 United Kingdom   Start Trial PRODUCT NAME: GADOXETIC ACID, OPTIONALLY IN THE FORM OF A SALT; REGISTERED: SE 18929 20040326; SE 18930 20040326; UK PL 00053/0348 20041110; UK PL 00053/0349 20041110
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Johnson and Johnson
AstraZeneca
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.